This quarter, the small-cap-tracking Russell 2000 index has outperformed the S&P 500, which measures the performance of the largest publicly traded companies in the U.S. This comes amid rising market expectations for Fed rate cuts. Since last summer, interest rates have been at their highest level in 22 years, notes…
On Wednesday, September 11, quotes on Gatekeeper Systems, a Canada-based solutions provider for public transportation and smart cities, surged about 20% in Toronto and New York. The trigger was preliminary financial results for the fiscal-2024 fourth quarter and full year (ended August 31), which showed record revenue. Details On Wednesday,…
Shares of telecom company AST SpaceMobile, which aims to compete with Elon Musk‘s SpaceX, have skyrocketed over 1,300% since April, when they hit an all-time low. The growth makes AST SpaceMobile the top-performing stock in the small-cap Russell 2000 index over the last six months, Bloomberg reports. The latest gains…
Zacks Small-Cap Research has released a report on Tonix Pharmaceuticals, which is developing a monkeypox vaccine, valuing the stock at $4 per share, nearly 26 times the last closing price. The company’s current market capitalization is around $3.3 million. Details The fair value of a Tonix share is $4, estimates…
Small-cap stocks may be poised for a big rally in the next 6-12 months, according to Sean Gallagher, who oversees investments in the asset class at Lazard. He estimates that the Russell 2000 index could gain as much as 30-50% amid Fed rate cuts. Details Sean Gallagher, the global head…
Canada’s Lexaria Bioscience, with a market capitalization of just over $50 million on the Nasdaq, is in the business of transforming the delivery of other companies’ drugs. After years of trying to find its niche, the company now intends to make globally best-selling injectable diabetes and obesity drugs from Novo…
Shares of Terns Pharmaceuticals, a biotech company with a market capitalization of $641.8 million, surged nearly 17% on Monday, September 9. The trigger was clinical trial results showing that more than half of the patients using the highest dose of the company’s oral weight-loss drug lost 5% of their body…
Quotes on Mama’s Creations, a maker of pre-prepared foods with a market capitalization of $298.1 million, rose 4.6% on Monday, September 9. Earlier in the day, the company announced that Skip Tappan, a manager with experience at Walmart, Procter & Gamble, and Campbell Soup, would be taking over as COO.…
The global shift toward digitalization is creating opportunities across various markets as companies integrate AI, machine learning, and blockchain technologies. Zacks has fingered three stocks that could benefit from the rapid growth in what it calls the technology services market: the small caps Byrna Technologies and Climb Global Solutions, as…
SatixFy, an Israeli company with a market capitalization of $60.4 million that develops satellite communication systems, has reported that its net loss more than halved year over year in the first half of 2024. Revenue rose 7% as the company shifted from development and preproduction to product sales. Quotes on…
On Thursday, September 5, quotes on late-stage pharmaceutical company Citius Oncology added more than 8%. The company announced that its only approved drug so far, LYMPHIR, made to treat lymphoma, had been added to clinical practice guidelines in oncology, which makes it easier for doctors to prescribe and for insurers…
The U.S. company PSQ Holdings, also known as PublicSquare, brands itself as a marketplace for family-oriented, patriotic and politically conservative Americans. Three years ago, it was just an idea, a few lines of code, and seven employees. “We will become the new Amazon,” proclaims its founder, Michael Seifert. While the…
On Wednesday, September 4, display manufacturer Daktronics saw its stock drop more than 9% after releasing previous-quarter financials. Sales fell 2.8% year over year, while earnings per share missed analysts’ expectations. Details On Wednesday, Daktronics stock lost 9.11% to $12.37 per share, the decline continuing in pre-market trading on Thursday.…
On Wednesday, September 4, quotes on Athira Pharma, a small developer of therapies for neuronal health, plummeted 78% after the company reported that its Alzheimer’s treatment had not been found significantly more effective than placebo in a 26-week clinical trial. Despite this setback, Athira intends to continue working on the…
Canada’s KITS Eyecare, a retailer of eyewear and contact lenses, has upgraded its revenue guidance for the third quarter of 2024 just a month after announcing the previous estimate. Analysts have taken note and raised their target prices for the stock. Details KITS Eyecare has announced that it sees upside…
Shares of less-lethal weapons manufacturer Byrna Technologies have surged more than 20% today, Wednesday, September 4. The trigger was preliminary third-quarter earnings, with revenue nearly tripling. Details At the start of trading on Wednesday, Byrna Technologies stock jumped 20.4% to $12.94 per share, the highest mark since May. For the…
The city of Stockholm has proposed revoking the Swedish sales permit for traditional snus from a Haypp Group subsidiary, the company reported. Snus in Sweden accounts for a fifth of total sales. Today, Wednesday, September 4, Haypp shares opened lower on the Nasdaq First North Growth Market for smaller European…
The stock of fintech company Pagaya Technologies is trading with 79% upside versus its last closing price, notes Barchart.com contributor Ruchi Gupta, citing analysts’ consensus forecasts. Pagaya has developed an AI platform that helps banks, retailers, and payment systems to make lending decisions. Details The average target price for Pagaya…
The consulting firm Grand View Research expects the global AI market to grow from less than $200 billion in 2023 to $1.8 trillion by 2030. Against this backdrop, the tech giants driving AI adoption are Wall Street favorites, making it increasingly difficult to find stocks with untapped potential. Insider Monkey…
Zacks Small-Cap Research (Zacks SCR) published a report last week on VolitionRx, which develops and sells early-detection tests for serious diseases. It set a target price for the stock of $3.60 per share, five times the closing price as of Friday, August 30, noting the company’s expanding distribution network and…
Shares of XORTX Therapeutics, which is focused on developing drug therapies to treat progressive kidney disease, soared about 136% on Thursday, August 29. The company highlighted research that established a link between genetic factors and several diseases, including kidney disease. This might expand the market for XORTX therapies, as the…
The unexpected entry of Kamala Harris into the presidential race on July 21 drove a 5.7% rise in the shares of AdvisorShares Pure US Cannabis ETF, which provides investors with access to U.S. cannabis companies, with a 19% increase in the number of shares changing hands. More than half of…
Shares of less-lethal weapons manufacturer Byrna Technologies rose 2.6% on Wednesday, August 28. The company announced that the Uruguayan government had purchased launchers and ammunition for use by the National Police. Details Byrna stock gained 2.56% to $11.22 per share on the Nasdaq on Wednesday, having risen as high as…
Sonoma Pharmaceuticals, which develops treatments for dermatological conditions and advanced wound care with its flagship product stabilized hypochlorous acid, slid almost 14% in pre-market trading today, Wednesday, August 28. This follows an announced reverse stock split to maintain the company’s listing. Details In trading before the open on Wednesday, Sonoma…
